E Kandil Selected Research

Congenital Hyperinsulinism

5/2011

Is octreotide safe for the management of persistent hyperinsulinemic hypoglycemia of infancy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Kandil Research Topics

Disease

2	Hemorrhage 01/2018 - 12/2011
2	Cognitive Dysfunction 09/2001 - 07/2001
1	Thyroid Nodule (Nodule, Thyroid) 01/2018
1	Papillary Thyroid Cancer 10/2017
1	Recurrent Laryngeal Nerve Injuries 10/2017
1	Neoplasms (Cancer) 01/2014
1	Paraganglioma (Paragangliomas) 01/2014
1	Insulinoma 01/2012
1	Graves Disease (Basedow Disease) 12/2011
1	Thyroid Diseases (Thyroid Disease) 12/2011
1	Congenital Hyperinsulinism 05/2011
1	Primary Hyperparathyroidism 01/2009
1	Edema (Dropsy) 09/2004
1	Pancreatitis 09/2004
1	Atrophy 07/2001
1	Alzheimer Disease (Alzheimer's Disease) 07/2001

Drug/Important Bio-Agent (IBA)

1	CatecholaminesIBA 01/2014
1	CalciumIBA 01/2012
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2011
1	Protein Isoforms (Isoforms)IBA 09/2004
1	Antisense OligodeoxyribonucleotidesIBA 09/2004
1	C-Reactive ProteinIBA 09/2004
1	Pancreatitis-Associated ProteinsIBA 09/2004
1	OligodeoxyribonucleotidesIBA 09/2004
1	Proteins (Proteins, Gene)FDA Link 09/2004
1	CytokinesIBA 09/2004
1	Amylases FDA Link 09/2004
1	Deoxyglucose (2 Deoxy D glucose)IBA 09/2001
1	Glucose (Dextrose)FDA LinkGeneric 07/2001

Therapy/Procedure

2	Thyroidectomy 10/2017 - 12/2011
1	Local Anesthesia 01/2018
1	Therapeutics 01/2014
1	Contraindications 12/2011
1	Parathyroidectomy 01/2009
1	Injections 09/2004